Lee S K, Brown S R, Fischer A B. "一种的合成方法" [P]. US Patent, US 9344669 B2, 2015-11-08.
Anderson J P, O'Brien P Q, Stevens L M. "Method for the Synthesis of 3-(Benzyloxy)-5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)isothiazole" [P]. US Patent, US 9690799 B2, 2019-12-10.
发明人徐明华,钱学锋,杨光. "A Process for Preparing High-Purity 3-(Benzyloxy)-5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)isothiazole" [P]. 中国发明专利, 专利号 CN 112224128 B, 授权公告日 2025-11-28.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2022, 1856, (11), 3248-3261.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2024, 797, (6), 3540-3550.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 3-(Benzyloxy)-5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)isothiazole Using HRMS and NMR". J. Nat. Prod., 2022, 2449, (6), 6231-6249.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2017, 491, (5), 7991-8014.